CTLA4-eADCC
HBM4003
CCR8-eADCC
HBM1022
CD25-eADCC
HBM1039
MSLN-ADC
HBM9033
CEACAM-ADC
HBM1053
CD73
HBM1007
B7H7
HBM1020
CD200R1
HBM1047
SigLec-7/9
HBM1057
CD36
HBM1055
LIFR
HBM9014
激活免疫细胞
T Cell Engager
CD3 HBICE®
BCMAxCD3
HBM7020
B7H4xCD3
HBM7004
CLDN18.2xCD3
AZD5863/HBM7022
4-1BB HBICE®
B7H4x4-1BB
HBM7008
MSLNx4-1BB
HBM7021
CD28 HBICE®
PDL1xCD28
HBM7024
BiKE
NKp30 HBICE®
ROR1xNKp30
HBM7025
BiME/BiDE
CD40 HBICE®
PDL1xCD40
HBM9027
5T4xCD40
HBM7023
T and NK
Other HBICE®
CD122xCD132
HBM1040
CRTAM
HBM1054
直接杀伤:
剔除Treg细胞或肿瘤细胞,通过eADCC及下一代ADC激活免疫细胞:
通过免疫细胞衔接器双抗HBICE®克服免疫抑制:
通过H2L2/HCAb/SBC技术,调节除PD-(L)1以外的其它免疫逃逸通路FcRn
HBM9161
TSLP
HBM9378
SARS-COV-2
HBM9022